1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with acetylcysteine in 9 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 14,580 | 1,046 | 5,960 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, GR; Christman, BW | 1 |
| Bernard, GR; Weikert, LF | 1 |
| Choi, IW; Choi, JH; Chung, WJ; Han, SJ; Han, SS; IM, SY; Jang, KY; Lee, DG; Lee, HB; Lee, HK; Park, KH | 1 |
| Andersson, R; Börjesson, A; Haraldsen, P; Lasson, A; Olanders, K; Sun, ZW | 1 |
| Descamps-Latscha, B; Drüeke, T; Gausson, V; Nguyen, AT; Santangelo, F; Touam, M; Witko-Sarsat, V | 1 |
| Andersson, R; Börjesson, A; Olanders, K; Sun, ZW | 1 |
| Büchler, MW; Gebhard, MM; Hackert, T; Hartwig, W; Kaiser, H; Klar, E; Schmidt, J; Werner, J | 1 |
| Uomo, G | 1 |
| Abhilasha, KV; Chaithra, VH; Chen, CH; Jacob, SP; Kemparaju, K; Marathe, GK; Prabhu, KS; Rajaiah, R; Sahu, RP; Sumanth, MS; Thyagarajan, A; Travers, JB | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and acetylcysteine
| Article | Year |
|---|---|
Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Epoprostenol; Humans; Inflammation; Intensive Care Units; Leukotrienes; Lipid Peroxidation; Middle Aged; Platelet Activating Factor; Respiratory Distress Syndrome; Thromboxanes; Treatment Failure | 1993 |
Pharmacotherapy of sepsis.
Topics: Acetylcysteine; Antioxidants; Bradykinin; Cyclooxygenase Inhibitors; Humans; Naloxone; Pentoxifylline; Platelet Activating Factor; Sepsis | 1996 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and acetylcysteine
| Article | Year |
|---|---|
Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB.
Topics: Acetylcysteine; Animals; Antioxidants; Azepines; Benzoquinones; Disseminated Intravascular Coagulation; DNA-Binding Proteins; Female; Gene Expression Regulation; Genistein; Hemorrhage; Hydrogen Peroxide; I-kappa B Proteins; Isoflavones; Kidney Medulla; Lactams, Macrocyclic; Lethal Dose 50; Macrophages; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Platelet Activating Factor; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pulmonary Edema; Pyrrolidines; Quinones; Reactive Oxygen Species; Rifabutin; Serine Proteinase Inhibitors; Signal Transduction; Specific Pathogen-Free Organisms; Succinic Acid; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Triazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2000 |
Multimodal management - of value in fulminant acute pancreatitis?
Topics: Acetylcysteine; Acute Disease; Animals; Antibodies, Monoclonal; Capillary Permeability; Drug Therapy, Combination; Free Radical Scavengers; Imidazoles; Leucine; Male; Pancreatitis; Platelet Activating Factor; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley | 2003 |
AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients.
Topics: Acetylcysteine; Blood Proteins; Dose-Response Relationship, Drug; Humans; Monocytes; NADP; Neutrophils; Oxidation-Reduction; Oxygen; Peroxidase; Platelet Activating Factor; Serum Albumin; Uremia | 2003 |
Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
Topics: Acetylcysteine; Animals; Cytoprotection; Free Radical Scavengers; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Intestines; Ischemia; Leucine; Male; Neutrophil Infiltration; Permeability; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2003 |
Multidrug strategies are effective in the treatment of severe experimental pancreatitis.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Arginine; Dextrans; Disease Models, Animal; Drug Therapy, Combination; Free Radical Scavengers; Intercellular Adhesion Molecule-1; Male; Microcirculation; Nitric Oxide Donors; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Protease Inhibitors; Rats | 2012 |
Lesson from acute experimental pancreatitis: multidrug strategies is effective than single-target therapy.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Arginine; Disease Models, Animal; Drug Therapy, Combination; Free Radical Scavengers; Gabexate; Humans; Intercellular Adhesion Molecule-1; Male; Microcirculation; Nitric Oxide Donors; Pancreas; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Protease Inhibitors; Rats; Survival Analysis; Survival Rate; Treatment Outcome | 2012 |
p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice.
Topics: Acetylcysteine; Animals; Death, Sudden; Enzyme Inhibitors; Female; Free Radical Scavengers; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Protective Agents; Reactive Oxygen Species | 2019 |